2342-67-8

Usage

Uses

Used in Pharmaceutical Industry:
3,3,3-Trifluoropropyl 4-Methylbenzenesulfonate is used as a reactant for the preparation of amino-substituted isoxazoles, which are known for their antitumor properties. The compound plays a crucial role in the synthesis of these potential cancer-fighting agents, contributing to the development of novel therapeutic options for various types of cancer.

InChI:InChI=1/C10H11F3O3S/c1-8-2-4-9(5-3-8)17(14,15)16-7-6-10(11,12)13/h2-5H,6-7H2,1H3

Upstream product

• 460-37-7 1,1,1-trifluoro-3-iodopropane 
• 16836-95-6 silver(I) 4-methylbenzenesulfonate 
• 429-60-7 3,3,3-trifluoropropyltrimethoxysilane 
• 98-59-9 p-toluenesulfonyl chloride 
• 2240-88-2 3,3,3-Trifluoropropanol 
• 104-15-4 toluene-4-sulfonic acid 

Downstream Products

• 81430-68-4 1-ethyl-2-methyl-3,3,3-trifluoropropyl-4,5,6,7-tetrafluorobenzimidazolium p-toluenesulfonate 

Relevant academic research and scientific papers

6,7-Dihydro-5H-benzo[7]annulene derivatives, processes for their preparation, pharmaceutical products comprising them and their use for preparing medicaments

The invention relates to selective oestrogen receptor modulators (SERMs) and to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis

6,7-DIHYDRO-5H-BENZO[7]ANNULENE DERIVATIVES, PROCESS FOR PREPARATION THEREOF, PHARMACEUTICAL PREPARATIONS COMPRISING THEM, AND THE USE THEREOF FOR PRODUCTION OF MEDICAMENTS

The invention relates to selective oestrogen receptor modulators (SERM) and methods of production thereof, use thereof for the treatment and/or prophylaxis of diseases and use thereof for the production of medicinal products for the treatment and/or proph

NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS

Disclosed herein are cannabinoid receptor ligands of formula (I) wherein A1, A5, Rx, X4, and z are as defined in the specification. Compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and compositions are also disclosed.

Compounds Which Selectively Modulate The CB2 Receptor

Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally usefu